Beneficial Effect of Creatine Supplementation in Knee Osteoarthritis
Carregando...
Citações na Scopus
44
Tipo de produção
article
Data de publicação
2011
Editora
LIPPINCOTT WILLIAMS & WILKINS
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
GUALANO, Bruno
ROSCHEL, Hamilton
BENATTI, Fabiana Braga
LANCHA JR., Antonio Herbert
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, v.43, n.8, p.1538-1543, 2011
Resumo
NEVES JR., M., B. GUALANO, H. ROSCHEL, R. FULLER, F. B. BENATTI, A. L. DE SA PINTO, F. R. LIMA, R. M. PEREIRA, A. H. LANCHA JR., E. BONFA. Beneficial Effect of Creatine Supplementation in Knee Osteoarthritis. Med. Sci. Sports Exerc., Vol. 43, No. 8, pp. 1538-1543, 2011. Introduction: The aim of this study was to investigate the efficacy of creatine (CR) supplementation combined with strengthening exercises in knee osteoarthritis (OA). Methods: A randomized, double-blind, placebo-controlled trial was performed. Postmenopausal women with knee OA were allocated to receive either CR (20 g.d(-1) for 1 wk and 5 g.d(-1) thereafter) or placebo (PL) and were enrolled in a lower limb resistance training program. They were assessed at baseline (PRE) and after 12 wk (POST). The primary outcome was the physical function as measured by the timed-stands test. Secondary outcomes included lean mass, quality of life, pain, stiffness, and muscle strength. Results: Physical function was significantly improved only in the CR group (P = 0.006). In addition, a significant between-group difference was observed (CR: PRE = 15.7 +/- 1.4, POST = 18.1 +/- 1.8; PL: PRE = 15.0 +/- 1.8, POST = 15.2 +/- 1.2; P = 0.004). The CR group also presented improvements in physical function and stiffness subscales as evaluated by the Western Ontario and McMaster Universities Osteoarthritis Index (P = 0.005 and P = 0.024, respectively), whereas the PL group did not show any significant changes in these parameters (P > 0.05). In addition, only the CR group presented a significant improvement in lower limb lean mass (P = 0.04) as well as in quality of life (P = 0.01). Both CR and PL groups demonstrated significant reductions in pain (P G 0.05). Similarly, a main effect for time revealed an increase in leg-press one-repetition maximum (P = 0.005) with no significant differences between groups (P = 0.81). Conclusions: CR supplementation improves physical function, lower limb lean mass, and quality of life in postmenopausal women with knee OA undergoing strengthening exercises.
Palavras-chave
ARTHRITIS, EXERCISE TRAINING, NUTRITION, PHYSICAL FUNCTION, LEAN MASS
Referências
- Altman RD, 2010, AM J MANAG CARE, V16, pS41
- ALTMAN RD, 1987, J RHEUMATOL, V14, P3
- American College of Rheumatology Subcommittee on Osteoarthritis Guidelines, 2000, ARTHRITIS RHEUM, V43, P1905, DOI 10.3899/JRHEUM.090058
- Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
- Roy BD, 2005, ARCH PHYS MED REHAB, V86, P1293, DOI 10.1016/j.apmr.2005.01.005
- Chung YL, 2007, ARTHRIT RHEUM-ARTHR, V57, P694, DOI 10.1002/art.22687
- Segal NA, 2010, OSTEOARTHR CARTILAGE, V18, P769, DOI 10.1016/j.joca.2010.02.002
- Gotshalk LA, 2002, MED SCI SPORT EXER, V34, P537, DOI 10.1097/00005768-200203000-00023
- Terjung RL, 2000, MED SCI SPORT EXER, V32, P706
- NEWCOMER KL, 1993, J RHEUMATOL, V20, P21
- WALLIMANN T, 1992, BIOCHEM J, V281, P21
- Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014
- Deldicque L, 2005, MED SCI SPORT EXER, V37, P731, DOI 10.1249/01.MSS.0000162690.39830.27
- BELLAMY N, 1988, J RHEUMATOL, V15, P1833
- Lequesne MG, 1997, J RHEUMATOL, V24, P779
- Jan MH, 2008, PHYS THER, V88, P427, DOI 10.2522/ptj.20060300
- Lange AK, 2008, ARTHRIT RHEUM-ARTHR, V59, P1488, DOI 10.1002/art.24118
- Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359.x
- Canete S, 2006, J STRENGTH COND RES, V20, P22
- Louis M, 2003, MUSCLE NERVE, V27, P604, DOI 10.1002/mus.10355
- Slemenda C, 1997, ANN INTERN MED, V127, P97
- Tarnopolsky M, 1999, NEUROLOGY, V52, P854
- WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955
- Gotshalk LA, 2008, EUR J APPL PHYSIOL, V102, P223, DOI 10.1007/s00421-007-0580-y
- Kley RA, 2008, J NEUROL NEUROSUR PS, V79, P366, DOI 10.1136/jnnp.2007.127571
- Brose A, 2003, J GERONTOL A-BIOL, V58, P11
- Ritter PL, 2006, J RHEUMATOL, V33, P574
- Bender A, 2008, NUTR RES, V28, P172, DOI 10.1016/j.nutres.2008.01.001
- FUNANAGE VL, 1992, BONE MINER, V17, P228, DOI 10.1016/0169-6009(92)90742-V
- Gerber I, 2005, Eur Cell Mater, V10, P8
- GRANSTROM G, 1986, SCAND J DENT RES, V94, P1
- Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd
- KATOH R, 1991, CLIN ORTHOP RELAT R, P283
- Persky Adam M., 2007, V46, P275
- Valderrabano V, 2011, J AGING RES, V2011
- WYSS M, 1994, MOL CELL BIOCHEM, V133, P51, DOI 10.1007/BF01267947